We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
febit to Introduce Geniom RT Analyzer® to U.S. Market at RNAi World Congress
Product News

febit to Introduce Geniom RT Analyzer® to U.S. Market at RNAi World Congress

febit to Introduce Geniom RT Analyzer® to U.S. Market at RNAi World Congress
Product News

febit to Introduce Geniom RT Analyzer® to U.S. Market at RNAi World Congress


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "febit to Introduce Geniom RT Analyzer® to U.S. Market at RNAi World Congress"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

febit holding gmbh has announced it will introduce the Geniom RT Analyzer® to the U.S. market at RNAi World Congress, which will take place April 30-May 2 in Boston.

According to Company, RNA-researchers, one of the main user groups of its new device, will benefit from the microarray technology device's high degree of automation and flexibility. In addition, microRNA researchers will enjoy its recently released microarray based on Sanger miRBase-Version 11.0.

The latest product in febit's Geniom family, the Geniom RT Analyzer is designed to enable the fully automated processing of microarrays on febit's own Geniom biochips. The compact all-in-one device, which employs microfluidics, can provide users with high sample throughput, reproducibility and a variety of applications. In addition, the product's freely programmable and temperature control optimizes hybridizations and can enable the use of enzymatic reactions directly on the microfluidic array for signal enhancement and primer extension assays.

Advertisement